Infections and anti–tumor necrosis factor α therapy
Open Access
- 4 November 2003
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (11), 3013-3022
- https://doi.org/10.1002/art.11301
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Induction of Interleukin-12 and Gamma Interferon Requires Tumor Necrosis Factor Alpha for Protective T1-Cell-Mediated Immunity to PulmonaryCryptococcus neoformansInfectionInfection and Immunity, 2002
- Tuberculosis and Treatment with InfliximabNew England Journal of Medicine, 2002
- Effect of Deficiency of Tumor Necrosis Factor Alpha or Both of Its Receptors onStreptococcus pneumoniaeCentral Nervous System Infection and PeritonitisInfection and Immunity, 2001
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Invasive Pulmonary Aspergillosis Associated with Infliximab TherapyNew England Journal of Medicine, 2001
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infectionCell, 1989
- Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic StudyJNCI Journal of the National Cancer Institute, 1988
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985